NORTH CHICAGO, Ill., Sept. 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the start of construction of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago ...

Astorg, EQT, New Mountain Capital and TA Associates are among the PE firms buying and selling active pharmaceutical ingredient assets.

A look at the active pharmaceutical ingredients (API) sector, which has attracted the likes of Astorg, EQT, TA Associates and New Mountain Capital; an agreement by American Securities to sell a ...

Pharmaceutical giant AbbVie is planning a $380 million investment in two new manufacturing facilities at its campus in North ...

Investment marks continued progress against AbbVie's $100 billion commitment to U.S. research and development (R&D) and capital investments, including manufacturing, over the next decade Two new ...

NORTH CHICAGO, Ill., Aug. 12, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ...

Biopharmaceutical company AbbVie plans to spend $380 million building two new manufacturing facilities in North Chicago — a ...

Highly potent active pharmaceutical ingredients (HPAPIs) are at the forefront of pharmaceutical manufacturing. They are particularly common in targeted therapies and personalized medicines. This is ...

A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. have landed in the FDA’s crosshairs thanks to quality shortfalls, poor testing standards ...

India's active pharmaceutical ingredient (API) exports have reached Rs 41,500 crore, surpassing imports. The government's production-linked incentive scheme aims to bolster domestic manufacturing, ...

New $195 million facility will further enhance AbbVie's active pharmaceutical ingredient (API) production capacity and capabilities in the U.S. Expansion is part of AbbVie's previously announced ...